NewGenIvf Group Limited (NIVF)

USD 0.33

(-23.27%)

EBITDA Summary of NewGenIvf Group Limited

  • NewGenIvf Group Limited's latest annual EBITDA in 2023 was -2.52 Million USD , down -399.42% from previous year.
  • NewGenIvf Group Limited's latest quarterly EBITDA in 2023 FY was N/A , down -399.42% from previous quarter.
  • NewGenIvf Group Limited reported an annual EBITDA of -504.9 Thousand USD in 2022, down -186.01% from previous year.
  • NewGenIvf Group Limited reported an annual EBITDA of 587.01 Thousand USD in 2021, down 0.0% from previous year.
  • NewGenIvf Group Limited reported a quarterly EBITDA of N/A for 2023 FY, down -399.42% from previous quarter.
  • NewGenIvf Group Limited reported a quarterly EBITDA of -1.26 Million USD for 2023 Q4, down -235.26% from previous quarter.

Annual EBITDA Chart of NewGenIvf Group Limited (2023 - 2021)

Historical Annual EBITDA of NewGenIvf Group Limited (2023 - 2021)

Year EBITDA EBITDA Growth
2023 -2.52 Million USD -399.42%
2022 -504.9 Thousand USD -186.01%
2021 587.01 Thousand USD 0.0%

Peer EBITDA Comparison of NewGenIvf Group Limited

Name EBITDA EBITDA Difference
Alignment Healthcare, Inc. -105.29 Million USD 97.605%
Clover Health Investments, Corp. -210.84 Million USD 98.804%
Marpai, Inc. -20.97 Million USD 87.978%